{
    "@context": "http://id.who.int/icd/contexts/contextForICD10Entity.json",
    "@id": "http://id.who.int/icd/release/10/2016/P04.1",
    "parent": [
        "http://id.who.int/icd/release/10/2016/P04"
    ],
    "browserUrl": "http://apps.who.int/classifications/icd10/browse/2016/en#/P04.1",
    "code": "P04.1",
    "title": {
        "@language": "en",
        "@value": "Fetus and newborn affected by other maternal medication"
    },
    "inclusion": [
        {
            "label": {
                "@language": "en",
                "@value": "Cancer chemotherapy"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "Cytotoxic drugs"
            }
        }
    ],
    "exclusion": [
        {
            "label": {
                "@language": "en",
                "@value": "dysmorphism due to warfarin"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "fetal hydantoin syndrome"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "maternal use of drugs of addiction"
            }
        }
    ],
    "classKind": "category"
}